Lexaria Bioscience Corp (LEXX)
2.29
-0.08
(-3.38%)
USD |
NASDAQ |
Dec 27, 16:00
2.26
-0.03
(-1.31%)
After-Hours: 20:00
Lexaria Bioscience Free Cash Flow: -5.148M for Aug. 31, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Aurinia Pharmaceuticals Inc | 28.30M |
| Edesa Biotech Inc | -4.890M |
| Xenon Pharmaceuticals Inc | -158.99M |
| ESSA Pharma Inc | -22.72M |
| ImmunoPrecise Antibodies Ltd | -6.657M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.892M |
| Cash from Investing (Quarterly) | -0.0696M |
| Free Cash Flow Per Share (Quarterly) | -0.1248 |
| Free Cash Flow to Equity (Quarterly) | -1.961M |
| Free Cash Flow Yield | -18.21% |